NEW ON THE MARKET
Osteoporosis drug abaloparatide (ELADYNOS)
Background: osteoanabolic osteoporosis drugs
Risankizumab (SKYRIZI) for ulcerative colitis
IN BRIEF
Despite the SELECT trial: semaglutide as WEGOVY remains exclusively a lifestyle drug
ESC guideline recommends screening for atrial fibrillation despite new negative trials free article
Blood pressure measurement: the correct arm position
Supply shortages, stockpiling, exemptions for imports: no improvement in the supply of medicines in sight
a-t READERS QUESTIONS AND COMMENTS
Oviva direkt for obesity: overreaching marketing by the provider of the digital health application
Ivermectin-containing cream SOOLANTRA against rosacea: drastic price increase
BEWARE MISINFORMATION
Is a reduction in all-cause mortality for the COPD inhaler TRIXEO AEROSPHERE actually proven?
SIDE EFFECTS
Fibroadenomas with ciclosporin
Finasteride, dutasteride: EMA examines data on suicidality